Nonprofit

Title Due Date Maximum Award Amount Sort descending Description
Strategic Growth Council's Technical Assistance Program No Due Date Given Varies

The program provides application assistance, partnership development and capacity building activities for eligible California Climate Investments applicants and is administered by the Strategic Growth Council to create more equitable opportunities by helping under-resourced applicants access funding.

The California Climate Investments Technical Assistance Program supports communities in applying to the California Climate Investments (CCI) funding programs. Created in 2016, the program aims to level the playing field for applicants that may lack the capacity to successfully access these funds, particularly those in that live in the state’s most disadvantaged communities. The Strategic Growth Council (SGC) works alongside a number of State agencies that implement CCI programs to provide application assistance, partnership development and capacity building activities to eligible applicants, enabling them to positively impact their communities. 

Each California Climate Investments program has its own set of goals and intended outcomes, meaning specific technical expertise is often required. In order to provide assistance that is tailored to each program, the SGC has divided resources amongst many of the agencies that administer programs. In many cases, technical assistance is provided through a partnership between state agencies and outside organizations with expertise in each program’s focus. A description of each of the participating CCI programs is listed below.

http://sgc.ca.gov/programs/tech/resources/
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) Varies

The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat substance misuse and chronic pain. Research of interest includes but is not limited to Stage I research.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=340174
Workshops on Computational and Analytical Research Methods (R25 - Clinical Trial Not Allowed) Varies

oThe purpose of this concept is to invite R25 applications that disseminate analytical and computational methodologies and best practices through educational activities with hands-on research experience.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=340322
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Varies

This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists.The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investigators. These non-tenure track scientists, such as researchers within a research program, are vital to sustaining the biomedical research enterprise. It is anticipated that only exceptional scientists who want to pursue research within the context of an existing NCI-funded cancer research program, but not serve as independent investigators, will be competitive for this award.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=340748
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) Varies

The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects that investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal the PAIRS program is to the development of radiation-synthetic combination strategies and facilitate their adoption into the precision medicine toolkit toward building new and effective anticancer treatments.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=341117
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) Varies

The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to encourage and retain outstanding graduate students recognized by their institutions for their high potential and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the transition of talented graduate students into successful cancer research postdoctoral appointments and provide opportunities for career development activities relevant to their long-term career goals of becoming independent cancer researchers.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=343185
HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Clinical Trial Not Allowed) Varies

This Funding Opportunity Announcement (FOA) invites grant applications to study the impact of opioids, alone or in combination with other substances of misuse, on placenta function and neurodevelopment during pregnancy and in the first year of life. Clinical Trials are not permitted for this FOA; researchers proposing Basic Experimental Studies with Humans (BESH) should consider the companion FOA, RFA-HD-23-032, HEAL Initiative: Opioid Exposure and Effects on Placenta Function, Brain Development, and Neurodevelopmental Outcomes (R01 Basic Experimental Studies with Humans Required).

https://www.grants.gov/web/grants/view-opportunity.html?oppId=343289
NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional) Varies

This funding announcement solicits R21 grant applications that propose exploratory/developmental research projects that are consistent with the research framework detailed in the 2022-2026 National Institute of Nursing Research (NINR) Strategic Plan. This research will be rooted in nursing's holistic, contextualized approach to understanding people and their health, address the nation's most pressing and persistent health challenges with a solutions orientation, and employ innovative and rigorous study designs to inform practice and policy.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=343420
BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed) Varies

This Funding Opportunity Announcement (FOA) intends to support a Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) that will be composed of four components to establish respectively (1) a common sequencing data processing pipeline, (2) a common imaging data processing pipeline, (3) a comprehensive brain cell knowledge base, and (4) an engaging and outreach component to coordinate the research within and beyond BICAN. The overall goals of CUBIE are to (i) enable the exploration of large-scale brain cell atlas data and knowledge, and inspire research in brain function and disorders; and (ii) ensure research rigor and data reproducibility by making the data to be findable, accessible, interoperable, and reusable, and the process transparent. An application is expected to propose only one of the above four respective components.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=343911
Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional) Varies

This Funding Opportunity Announcement (FOA) invites grant applications for Environmental Health Sciences Core Centers (EHS CC). As intellectual hubs for environmental health research, the EHS CC is expected to be the thought leaders for the field and advance the goals of the NIEHS Strategic Plan (http://www.niehs.nih.gov/about/strategicplan/).The Core Centers provide critical research infrastructure, shared facilities, services and/or resources, to groups of investigators conducting environmental health sciences research.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=344572